Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Novartis day

Novartis’ Farydak gets nod for myeloma in Europe

HDAC inhibitor offers new mechanism of action in fight against myeloma

- PMLiVE

Novartis launches first biosimilar Zarxio in the US

Follows Amgen's failure to block Neupogen-version from release

- PMLiVE

Pharma perspectives: communications creativity (part 2)

David Higgins from Sudler & Hennessey Group on what it means to be creative in healthcare communications

- PMLiVE

Pharma perspectives: communications creativity (part 1)

AstraZeneca business unit director Samuel Hollis on what healthcare communications creativity means to him

- PMLiVE

Frontera supports unique fashion auction for homeless charity

Eventis part of the agency's pro-bono work for London-based Pathway

- PMLiVE

Health board game developed to educate the young

TheFood, Mood and Health Game aims to help broach difficult food-related topics 

- PMLiVE

Novartis’ heart failure drug approved via early access scheme

LCZ696 issued positive scientific opinion under EAMS

Cello Health BioConsulting appoints Jim Hall as president

Senior pharma marketer to preside over newly-formed consulting firm

Bristol-Myers Squibb (BMS) building

BMS’ myeloma treatment accepted for priority review

If approved elotuzumab will be marketed as Empliciti

- PMLiVE

US Senator sets sights on medicine pricing

Intends to stop rises in drug prices for US public

Teva Pharma logo

Teva rolls out first migraine patch in US

Delivers alternative treatment option for migraine sufferers

- PMLiVE

Amgen and Novartis collaborate on Alzheimer’s research

Will work on the development and commercialisation of BACE inhibitors

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links